On the Bid is a new Stockhead video series featuring a roundtable of experts discussing a new investment topic each week.

In this edition, host Oriel Morrison discusses 3D Bioprinting tech, the rapid wave of innovation in the sector, drug development, the future of human cell production and the massive potential that organ printing has for the future of medicine. 

On the panel this week is Dr Lim Jing, chief technology officer at Osteopore (ASX:OSX) and Dr Cameron Ferris, co-founder and chief operating officer at Inventia Life Science.

The panel discuss a range of topics including; The incredible pace of innovation in the world of bioprinting, new advancements and drug development, future expansion plans for the companies and more.  

So click above to tune in!